Effects of N-n-butyl haloperidol iodide on the rat myocardial sarcoplasmic reticulum Ca2+-ATPase during ischemia/reperfusion

Biochemical and Biophysical Research Communications

Volumn 425, Issue 2, 2012, Pages 426-430

  Zhang, Yan Mei ^a   Wang, Chun Yan ^b   Zheng, Fu Chun ^a   Gao, Fen Fei ^a   Chen, Yi Cun ^a   Huang, Zhan Qin ^a   Xia, Zheng Yuan ^b   Irwin, Michael G ^b   Li, Wei Qiu ^a   Liu, Xing Ping ^a   Zheng, Yan Shan ^a   Xu, Han ^a   Shi, Gang Gang ^a  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Ischemia reperfusion; Myocardium; N n Butyl haloperidol iodide

Indexed keywords

HALOPERIDOL; N N BUTYL HALOPERIDOL IODIDE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE 2A; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; HEART MUSCLE ISCHEMIA; HEART PROTECTION; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY;

RATTUS;

EID: 84865391217     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.07.117     Document Type: Article

References (27)

1. Zhang Y.M., Shi G.G., Tang Z., Zheng J.H., Li W.Q., Guo F.X., Jia Q.Y. Effects of N-n-butyl haloperidol iodide on myocardial ischemia/reperfusion injury and egr-1 expression in rat. Acta Biochim. Biophys. Sin. (Shanghai) 2006, 38:435-441.
2. Zhang Y., Shi G., Zheng J., Tang Z., Gao P., Lv Y., Guo F., Jia Q. The protective effects of N-n-butyl haloperidol iodide on myocardial ischemia-reperfusion injury in rats by inhibiting egr-1 overexpression. Cell. Physiol. Biochem. 2007, 20:639-648.
3. Huang Z., Shi G., Gao F., Zhang Y., Liu X., Christopher T.A., Lopez B., Ma X. Effects of N-n-butyl haloperidol iodide on L-type calcium channels and intracellular free calcium in rat ventricular myocytes. Biochem. Cell Biol. 2007, 85:182-188.
4. Huang Z.Q., Shi G.G., Zheng J.H., Liu B. Effects of N-n-butyl haloperidol iodide on rat myocardial ischemia and reperfusion injury and L-type calcium current. Acta Pharmacol. Sin. 2003, 24:757-763.
5. Gao F.F., Hao S.Y., Huang Z.Q., Zhang Y.M., Zhou Y.Q., Chen Y.C., Liu X.P., Shi G.G. Cardiac electrophysiological and antiarrhythmic effects of N-n-butyl haloperidol iodide. Cell. Physiol. Biochem. 2010, 25:433-442.
6. Huang Y., Gao F., Zhang Y., Chen Y., Wang B., Zheng Y., Shi G. N-n-butyl haloperidol iodide inhibits the augmented Na+/Ca2+ exchanger currents and L-type Ca2+ current induced by hypoxia/reoxygenation or H2O2 in cardiomyocytes. Biochem. Biophys. Res. Commun. 2012, 421:86-90.
7. Talukder M.A., Kalyanasundaram A., Zhao X., Zuo L., Bhupathy P., Babu G.J., Cardounel A.J., Periasamy M., Zweier J.L. Expression of SERCA isoform with faster Ca2+ transport properties improves postischemic cardiac function and Ca2+ handling and decreases myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H2418-H2428.
8. Akolkar G., Pande J., Samson S.E., Grover A.K. Thapsigargin decreases the Na(+)-Ca(2+) exchanger mediated Ca(2+) entry in pig coronary artery smooth muscle. Biochim. Biophys. Acta 1818, 2012:730-737.
9. Talukder M.A., Kalyanasundaram A., Zuo L., Velayutham M., Nishijima Y., Periasamy M., Zweier J.L. Is reduced SERCA2a expression detrimental or beneficial to postischemic cardiac function and injury? evidence from heterozygous SERCA2a knockout mice. Am. J. Physiol. Heart Circ. Physiol. 2008, 294:H1426-H1434.
10. Pei J.M., Kravtsov G.M., Wu S., Das R., Fung M.L., Wong T.M. Calcium homeostasis in rat cardiomyocytes during chronic hypoxia: a time course study. Am. J. Physiol. Cell Physiol. 2003, 285:C1420-C1428.
11. Saito A., Seiler S., Chu A., Fleischer S. Preparation and morphology of sarcoplasmic reticulum terminal cisternae from rabbit skeletal muscle. J. Cell Biol. 1984, 99:875-885.
12. Xiao J.F., Wang C.Y., Huang Y.P., Shen J.X., Gao F.F., Huang Z.Q., Zheng Y.S., Shi G.G. N-n-butyl haloperidol iodide preserves cardiomyocyte calcium homeostasis during hypoxia/ischemia. Cell. Physiol. Biochem. 2011, 27:433-442.
13. Yellon D.M., Hausenloy D.J. Myocardial reperfusion injury. N. Engl. J. Med. 2007, 357:1121-1135.
14. Kang S.M., Lim S., Song H., Chang W., Lee S., Bae S.M., Chung J.H., Lee H., Kim H.G., Yoon D.H., Kim T.W., Jang Y., Sung J.M., Chung N.S., Hwang K.C. Allopurinol modulates reactive oxygen species generation and Ca2+ overload in ischemia-reperfused heart and hypoxia-reoxygenated cardiomyocytes. Eur. J. Pharmacol. 2006, 535:212-219.
15. Tang W.H., Kravtsov G.M., Sauert M., Tong X.Y., Hou X.Y., Wong T.M., Chung S.K., Man Chung S.S. Polyol pathway impairs the function of SERCA and RyR in ischemic-reperfused rat hearts by increasing oxidative modifications of these proteins. J. Mol. Cell. Cardiol. 2010, 49:58-69.
16. Seehase M., Quentin T., Wiludda E., Hellige G., Paul T., Schiffmann H. Gene expression of the Na-Ca2+ exchanger, SERCA2a and calsequestrin after myocardial ischemia in the neonatal rabbit heart. Biol. Neonate 2006, 90:174-184.
17. Hiranandani N., Bupha-Intr T., Janssen P.M. SERCA overexpression reduces hydroxyl radical injury in murine myocardium. Am. J. Physiol. Heart Circ. Physiol. 2006, 291:H3130-H3135.
18. Koga K., Kenessey A., Powell S.R., Sison C.P., Miller E.J., Ojamaa K. Macrophage migration inhibitory factor provides cardioprotection during ischemia/reperfusion by reducing oxidative stress. Antioxid. Redox Signal. 2011, 14:1191-1202.
19. Shih H.C., Huang M.S., Lee C.H. Estrogen augments the protection of hypertonic saline treatment from mesenteric ischemia-reperfusion injury. Shock 2011, 35:302-307.
20. Liu A., Fang H., Dirsch O., Jin H., Dahmen U. Early release of macrophage migration inhibitory factor after liver ischemia and reperfusion injury in rats. Cytokine 2012, 57:150-157.
21. Pande J., Dimmers G., Akolkar G., Skelley L., Samson S.E., Grover A.K. Store operated Ca2+ entry dependent contraction of coronary artery smooth muscle: inhibition by peroxide pretreatment. Cell Calcium 2012, 51:149-154.
22. Xu K.Y., Zweier J.L., Becker L.C. Hydroxyl radical inhibits sarcoplasmic reticulum Ca(2+)-ATPase function by direct attack on the ATP binding site. Circ. Res. 1997, 80:76-81.
23. Bhupathy P., Babu G.J., Periasamy M. Sarcolipin and phospholamban as regulators of cardiac sarcoplasmic reticulum Ca2+ ATPase. J. Mol. Cell. Cardiol. 2007, 42:903-911.
24. Yeung H.M., Hung M.W., Fung M.L. Melatonin ameliorates calcium homeostasis in myocardial and ischemia-reperfusion injury in chronically hypoxic rats. J. Pineal Res. 2008, 45:373-382.
25. Luss H., Boknik P., Heusch G., Muller F.U., Neumann J., Schmitz W., Schulz R. Expression of calcium regulatory proteins in short-term hibernation and stunning in the in situ porcine heart. Cardiovasc. Res. 1998, 37:606-617.
26. Wang J.Z., Cai C.Y., Zhang Y.M., Zheng J.H., Chen Y.C., Li W.Q., Shi G.G. N-n-butyl haloperidol iodide protects against hypoxia/reoxygenation-induced cardiomyocyte injury by modulating protein kinase C activity. Biochem. Pharmacol. 2010, 79:1428-1436.
27. Gao F.F., Shi G.G., Zheng J.H., Liu B. Protective effects of N-n-butyl haloperidol iodide on myocardial ischemia-reperfusion injury in rabbits. Chin. J. Physiol. 2004, 47:61-66.